Navigation Links
Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
Date:1/18/2008

ATLANTA, Jan. 18 /PRNewswire/ -- Elekta, a world leader in clinical solutions for radiation therapy and radiosurgery, announced today that two sites are utilizing Elekta technology to implement clinical treatments with Volumetric Modulated Arc Therapy (VMAT)*. With the recent CE designation of VMAT in Europe, the way has been cleared for The Royal Marsden Hospital in Sutton, UK and General Hospital Vienna in Austria to treat cancer using Elekta's VMAT solution.

VMAT is a significant improvement to existing advanced radiation therapy techniques, often referred to as IMRT (Intensity Modulated Radiation Therapy) and offers a faster alternative to helical tomotherapy. With Elekta's VMAT technology, the target continuously is radiated while the source of the beam is rotated around the patient in single or multiple arcs. By simultaneously controlling gantry position, gantry speed, leaves of the multi-leaf collimator (MLC), collimator angle and dose rate, a highly conformal dose distribution is created in significantly less time than with today's techniques. With VMAT from Elekta, a treatment session typically can be conducted in five minutes or less, including true 3D imaging to secure the location of the target.

"VMAT is a very promising technique," says Dietmar Georg, Ph.D., head of the Division of Medical Radiation Physics, Department of Radiotherapy, Medical University Vienna/General Hospital Vienna. "The rotational therapy and intensity modulation results in improved dose distribution and high conformality for optimal sparing of normal tissue." Using VMAT, Dr. Georg expects to see a more efficient workflow and faster treatments for patients receiving advanced radiotherapy.

Jim Warrington, head of Radiotherapy Physics at The Royal Marsden Hospital, says, "With the potential to produce megavoltage X-ray treatments of the highest quality and efficiency available, we anticipate VMAT will offer us greater flexibility as a radiotherapy treatment option."

Both sites have installed necessary system updates, and are eagerly anticipating the first VMAT treatments by the end of January.

Elekta leads the way with dynamic VMAT package

Elekta's solution for VMAT treatments is a complete package that includes MOSAIQ(TM), an image-enabled oncology Electronic Medical Records (EMR) system that supports each member of the cancer care team. The package also contains ERGO++ the first treatment planning system to employ inverse-planning techniques for rotational IMRT. When combined with existing digital linear accelerators, this system provides a simple, innovative solution for clinical VMAT cancer treatment.

As VMAT technology becomes the new standard in cancer care, Elekta continues to lead the way with advanced solutions for treating serious disease.

*Elekta Volumetric Intensity Modulated Arc Therapy (VMAT) is pending regulatory approvals in certain markets, including 510(k) clearance in the US, and is not yet for commercial sale in the US

About Elekta

Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders.

Elekta's systems and solutions are used in over 4,500 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife(R) for non-invasive treatment of brain disorders, Elekta Axesse(TM) and Elekta Synergy(R) for stereotactic and image guided radiation therapy and radiosurgery as well as the MOSAIQ(TM) suite of software for image-enabled EMR and efficient management of clinical and patient data.

With over 2,000 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at http://www.elekta.com.


'/>"/>
SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Elekta Announces Clinical Start-up of Elekta Synergy(R) S at UPMC
2. Elekta Negotiates To Acquire CMS
3. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
4. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
5. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
6. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
7. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
8. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
9. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
10. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
11. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... (PRWEB) , ... August 11, 2017 , ... A staple ... campaign this month that will incorporate important key elements including a new digital marketing ... community that has supported them, Bill Miller has partnered with the South Texas Blood ...
(Date:8/10/2017)... Warsaw, Indiana (PRWEB) , ... August 09, 2017 ... ... is equipped to help the agriculture industry reach its ideal customers with the ... across the nation. , “As a Midwest company, we realize how crucial the ...
(Date:8/10/2017)... , ... August 09, 2017 , ... Each year in ... never recover well enough to live an independent lifestyle and, even worse, the one-year ... new discovery by doctors at the University of California Davis Medical Center (Sacramento) and ...
(Date:8/10/2017)... ... 10, 2017 , ... DrugDev and the Society for Clinical ... how Good Clinical Practice (GCP) can be used throughout the site activation process with ... the importance of GCP compliance, how sites are affected by GCP during selection and ...
Breaking Biology Technology:
(Date:5/16/2017)... -- Veratad Technologies, LLC ( www.veratad.com ), an innovative and ... solutions, announced today they will participate as a sponsor ... May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions of ... digital world, defining identity is critical to nearly every ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
Breaking Biology News(10 mins):